UK Science and Industry collaboration successfully shows optical processing technology performing genetic sequence alignment significantly reducing HPC power consumption GLASSHOUGHTON, WEST YORKSHIRE, U.K. and NORWICH, U.K.– Optalysys Ltd. (@Optalysys), a start-up commercialising light-speed optical coprocessors for AI/deep learning, and world-leading genomic research institute The Earlham Institute, EI, (@EarlhamInst), today announced the successful completion of the Genetic […]
Almac Diagnostics selects DNAnexus for NGS-driven adaptive trial design to optimize and de-risk clinical trials, enabling the use of biomarkers in refining participant selection. MOUNTAIN VIEW, Calif. & CRAIGAVON, Northern Ireland–(BUSINESS WIRE)–DNAnexus, the global leader in biomedical informatics and data management, today announced the availability of its Clinical Trial Solution (CTS) which streamlines the use […]
Mountain View, CA—To advance the understanding of cell diversity and how that diversity impacts complex cellular functions including interactions with other cells and molecules, growth, and disease states, Takara Bio USA, Inc., (TBUSA, formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., is proud to announce the launch of the SMARTer ICELL8 cx […]
NEB® scientists, collaborators and customers to showcase data on new and upcoming NEBNext® technologies, including enzymatic DNA fragmentation, target enrichment, single cell RNA sequencing, and methylation analysis Ipswich, MA — Can an enzyme-based approach reliably and randomly generate DNA fragments for all GC contents and input amounts? How can each step in the next generation sequencing (NGS) library […]
Direct Labeling chemistry provides chromosome arm length maps and improves SV detection resolution down to 500 bp for as little as $500 per genome To be showcased at the AGBT General Meeting this week SAN DIEGO — Bionano Genomics, the genome mapping company, today announced the global commercial launch of new chemistry for sequence motif […]
Horizon out-licenses proprietary cell line and Helitron transposon gene editing technologies demonstrating Horizon’s ability to generate revenues from internally derived IP Horizon retains commercial rights over improvements to its technology platforms to develop new cell line technologies and gene delivery IP that can be licensed to customers for applications in biomanufacturing, diagnostic reference standards and […]
MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq:PACB) announced today that the U.S. International Trade Commission (the “ITC”) has terminated its investigation into whether Oxford Nanopore’s MinION and PromethION devices and associated consumables, reagents, and software infringe one or more claims of U.S. Patent Nos. 9,404,146 and 9,542,527, owned by Pacific Biosciences. The decision by the ITC is based on its […]
Strand Life Sciences announced an investment by Quadria Capital, Asia’s leading healthcare focused private equity investor. India-based HealthQuad Fund and Singapore-based Heritas Venture Fund also contributed to this fund. Strand Life Sciences, formed from the business combination of Strand and Triesta, the diagnostics unit of HCG, is India’s leading specialized diagnostics company. Its expertise spans […]
Funding will help develop new treatments for the commonest cause of chronic liver disease Eagle Genomics and the Stratified Medicine Scotland Innovation Centre (SMS-IC) have been awarded a £1.7M collaborative grant from Innovate UK (the UK’s innovation agency), for a ground-breaking project that could help develop new tests and treatments for patients with non-alcoholic fatty […]
Unique immune detection technology and flexible workflow for tuberculosis control efforts HILDEN, Germany & TOKYO–QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that Japan’s Ministry of Health Labor and Welfare has approved QuantiFERON®-TB Gold Plus (QFT®-Plus) as an in vitro diagnostic to detect tuberculosis (TB) infection. QFT-Plus is the fourth generation of QIAGEN’s […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
